ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Recent Registrations
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory    
January - February - March - April - May - June - July - August - September - Oktober - November - December | 2002 - 2003 - 2004 - 2005 - 2006 - 2007 - 2008 - 2009 - 2010 - 2011 - 2012 - 2013 - 2014 - 2015 - 2016 - 2017 - 2018 - 2019 - 2020 - 2021 - 2022 - 2023 - 2024 - 2025
December 2016 - 27 products
  IPCI Olmesartan Spirig HC 10mg3011.3028.7010 %Coated tablets: Olmesartanum Medoxomilum 10 mgSpirig HealthCare AGB / SL / SGGtell a friend
  IPCI Olmesartan Spirig HC 10mg10033.6252.9510 %Coated tablets: Olmesartanum Medoxomilum 10 mgSpirig HealthCare AGB / SL / SGGtell a friend
  IPCI Olmesartan Spirig HC 20mg3013.5731.1510 %Coated tablets: Olmesartanum Medoxomilum 20 mgSpirig HealthCare AGB / SL / SGGtell a friend
  IPCI Olmesartan Spirig HC 20mg10040.3660.3010 %Coated tablets: Olmesartanum Medoxomilum 20 mgSpirig HealthCare AGB / SL / SGGtell a friend
  IPCI Olmesartan Spirig HC 40mg3017.3135.2510 %Coated tablets: Olmesartanum Medoxomilum 40 mgSpirig HealthCare AGB / SL / SGGtell a friend
  IPCI Olmesartan Spirig HC 40mg10051.4972.3510 %Coated tablets: Olmesartanum Medoxomilum 40 mgSpirig HealthCare AGB / SL / SGGtell a friend
L IPCI Olmesartan-Amlodipin-
Mepha 20 mg/5 mg		2817.2235.1510 %Coated tablets: 2 Active AgentsMepha Pharma AGB / SL / SGGtell a friend
L IPCI Olmesartan-Amlodipin-
Mepha 20 mg/5 mg		9849.1869.8510 %Coated tablets: 2 Active AgentsMepha Pharma AGB / SL / SGGtell a friend
L IPCI Olmesartan-Amlodipin-
Mepha 40 mg/5 mg		2821.2939.5510 %Coated tablets: 2 Active AgentsMepha Pharma AGB / SL / SGGtell a friend
L IPCI Olmesartan-Amlodipin-
Mepha 40 mg/5 mg		9861.2983.0010 %Coated tablets: 2 Active AgentsMepha Pharma AGB / SL / SGGtell a friend
L IPCI Olmesartan-Amlodipin-
Mepha 40 mg/10 mg		2822.2040.5510 %Coated tablets: 2 Active AgentsMepha Pharma AGB / SL / SGGtell a friend
L IPCI Olmesartan-Amlodipin-
Mepha 40 mg/10 mg		9867.2489.5010 %Coated tablets: 2 Active AgentsMepha Pharma AGB / SL / SGGtell a friend
  IPCI Fosfolag 3 g 4.0213.6010 %granulato per soluzione orale: Fosfomycinum 3 gLagap SAA / SL / SGGtell a friend
L IPCIPPTaltz 80 mg 938.911037.5510 %Injection solution in prefilled syringe: Ixekizumabum 80 mgEli Lilly (Suisse) SAB / SLGtell a friend
L    Kalydeco 25 mg5611507.8312114.8510 %Granulate: Ivacaftorum 25 mgVertex
Pharmaceuticals (CH)
GmbH		A / SLGtell a friend
L    Kalydeco 50 mg5611507.8312114.8510 %Granulate: Ivacaftorum 50 mgVertex
Pharmaceuticals (CH)
GmbH		A / SLGtell a friend
L    Kalydeco 75 mg5611507.8312114.8510 %Granulate: Ivacaftorum 75 mgVertex
Pharmaceuticals (CH)
GmbH		A / SLGtell a friend
L IP  Darzalex 100mg/5ml 404.57456.4010 %Concentrate for infusion: Daratumumabum 100mg / 5mlJanssen-Cilag AGA / SLGtell a friend
L IP  Darzalex 400mg/20ml 1609.681767.0510 %Concentrate for infusion: Daratumumabum 400mg / 5mlJanssen-Cilag AGA / SLGtell a friend
  IPCIPPSoolantra 10 mg30 g16.3734.2010 %Cream: Ivermectinum 10 mgGalderma SAB / SLGtell a friend
  IPCIPhProstaplant-F6013.1430.7010 %Capsules: 2 Active AgentsSchwabe Pharma AGB / SLGtell a friend
  IPCIPhProstaplant-F12023.1241.5510 %Capsules: 2 Active AgentsSchwabe Pharma AGB / SLGtell a friend
L IPCI Saxenda 6 mg/ml392.41116.9010 %Injektionslösung im Fertigpen: Liraglutidum 6 mg/mlNovo Nordisk Pharma AGB / SLGtell a friend
L IPCI Saxenda 6 mg/ml5154.02183.9010 %Injektionslösung im Fertigpen: Liraglutidum 6 mg/mlNovo Nordisk Pharma AG● B / SL / LPPVGtell a friend
L IPCIPPTaltz 80 mg 938.911037.5510 %solution injectable en seringue préremplie: Ixekizumabum 80 mgEli Lilly (Suisse) SAB / SLGtell a friend
  IPCI Taptiqom 15mcg/ml +
5mg/ml		30 x 0.3 ml22.4740.8510 %unidose de collyre: 2 Active AgentsSanten SAB / SLGtell a friend
  IPCI Taptiqom 15mcg/ml +
5mg/ml		90 x 0.3 mlPRPRk.A.unidose de collyre: 2 Active AgentsSanten SABGtell a friend
 show caption
 
ATC-Browser | Drugs A-Z | Recent Registrations
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home